ArticleInternational journal of rheumatic diseases2026
Association Between Chikungunya Infection and Rheumatoid Arthritis in Taiwan-A Cross-Sectional Study.
Article in International journal of rheumatic diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Letter to Editor Regarding "Association Between Chikungunya Infection and Rheumatoid Arthritis in Taiwan-A Cross-Sectional Study".International journal of rheumatic diseases · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
objectivesChikungunya virus (CHIKV) infection might cause chronic chikungunya arthritis resembling rheumatoid arthritis (RA). The purpose of this study is to investigate the potential role of this virus in the pathogenesis of RA in Taiwan, a non-endemic area.
methodsThis cross-sectional study enrolled 98 RA patients and 200 healthy controls. Serum CHIKV IgM and IgG were tested using two commercial enzyme-linked immunosorbent assay (ELISA) kits (Abcam and Euroimmun) and an in-house neutralization assay. ELISA-IgM was performed only in patients with RA. ELISA or neutralization positive samples were further tested for CHIKV RNA by reverse-transcription-polymerase chain reaction. Associations between CHIKV seropositivity and various autoantibodies were analyzed. The agreements among these assays were also evaluated.
resultsNeutralizing antibodies were detected in 2 of 98 RA patients and in none of the controls (p = 0.107, Fisher's exact test; p = 0.043, chi-square). Both patients were absent from Abcam-IgM and -IgG, as well as Euroimmun-IgM and -IgG testing. There was no association between Abcam-IgM or Euroimmun-IgM and rheumatoid factor, anti-cyclic citrullinated peptide, antinuclear, or anti-extractable nuclear antigen antibodies. Poor agreements were noted between the neutralizing assay and Abcam-IgG or Euroimmun-IgG (κ = 0 and 0, respectively). A similar finding was also found between Abcam-IgM and Euroimmun-IgM (κ = -0.38).
conclusionOur study was not sufficiently powered to establish a causal association between CHIKV infection and RA development. Poor agreements were noted among different commercial ELISA kits and neutralization assays, underscoring the limitations of the serology assay.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.